日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcriptomic analysis of chronic social instability stress during adolescence reveals major shifts in the extracellular matrix

对青少年时期慢性社会不稳定压力的转录组分析揭示了细胞外基质的重大变化

Chu, Ming Yin; Hategan, Luca A; Leonetti, Amanda M; Ramnaraign, Fiona O; Holm, Samuel; Kannuri, Savithru; McLean, Timothy A B; Neira-Diaz, Laura; Malagi, Meghana C; McCormick, Cheryl M; Walters, Brandon J

Erratum: Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms

更正:PARP抑制剂尼拉帕尼治疗BAP1和其他DNA损伤反应通路缺陷型肿瘤的II期试验

George, Thomas J; Lee, Ji-Hyun; DeRemer, David L; Hosein, Peter J; Staal, Steven; Markham, Merry Jennifer; Jones, Dennie; Daily, Karen C; Chatzkel, Jonathan A; Ramnaraign, Brian H; Close, Julia L; Ezenwajiaku, Nkiruka; Murphy, Martina C; Allegra, Carmen J; Rogers, Sherise; Zhang, Zhongyue; Li, Derek; Srinivasan, Gayathri; Shaheen, Montaser; Hromas, Robert

Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic

在成人肿瘤诊所实施基于药物遗传学检测的药物治疗辅助治疗

Cicali, Emily J; Eddy, Elizabeth; Gong, Yan; Elchynski, Amanda L; Pena Del Aguila, Kim; Basha, Tala; Daily, Karen C; Dickson, Lauren; Fischer, Steven; Hastings-Monari, Erin; Jones, Dennie Jr; Ramnaraign, Brian H; DeRemer, David L; George, Thomas J; Cooper-DeHoff, Rhonda M

Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic

高危及晚期肾细胞癌(RCC)的治疗方法:影响临床治疗决策的关键试验数据

Chatzkel, Jonathan; Fishman, Mayer; Ramnaraign, Brian; O'Malley, Padraic; Sonpavde, Guru P

PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials

PSMA靶向放射性药物在前列腺癌治疗中的应用:最新数据和新试验

Ramnaraign, Brian; Sartor, Oliver

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

胰腺腺癌新辅助脂质体伊立替康联合5-氟尿嘧啶和奥沙利铂(NALIRIFOX)的II期研究

Singhal, Ruchi; Rogers, Sherise C; Lee, Ji-Hyun; Ramnaraign, Brian; Sahin, Ilyas; Fabregas, Jesus C; Thomas, Ryan M; Hughes, Steven J; Nassour, Ibrahim; Hitchcock, Kathryn; Russell, Karen; Kayaleh, Omar; Turk, Anita; Zlotecki, Robert; DeRemer, David L; George, Thomas J

Pneumocystis jirovecii pneumonia in a patient treated with trastuzumab-deruxtecan

接受曲妥珠单抗-德鲁替康治疗的患者发生卡氏肺囊虫肺炎

Mallah, Haneen; Altshuler, Ellery; Ramnaraign, Brian; Khawaja, Ali

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study

糖类抗原(CA 19-9)和癌胚抗原(CEA)在十二指肠腺癌患者预后中的重要性:一项回顾性单中心队列研究

Altshuler, Ellery; Richhart, Raymond; King, William; Aryan, Mahmoud; Mathavan, Akash; Mathavan, Akshay; Hones, Keegan; Leach, Daniel F 3rd; Pucci, Logan; Riklan, Joshua; Haley, Pat; Sahin, Ilyas; Ramnaraign, Brian; Rogers, Sherise; Nassour, Ibrahim; Hughes, Steven; George, Thomas J; Fabregas, Jesus

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study

附录:糖类抗原(CA 19-9)和癌胚抗原(CEA)在十二指肠腺癌患者预后中的重要性:一项回顾性单中心队列研究

Altshuler, Ellery; Richhart, Raymond; King, William; Aryan, Mahmoud; Mathavan, Akash; Mathavan, Akshay; Hones, Keegan; Leach, Daniel F 3rd; Pucci, Logan; Riklan, Joshua; Haley, Pat; Sahin, Ilyas; Ramnaraign, Brian; Rogers, Sherise; Nassour, Ibrahim; Hughes, Steven; George, Thomas J; Fabregas, Jesus

Trends in Use of Granulocyte Colony-Stimulating Factor Following Introduction of Biosimilars Among Adults With Cancer and Commercial or Medicare Insurance From 2014 to 2019

2014年至2019年,在患有癌症且拥有商业保险或医疗保险的成年人中,粒细胞集落刺激因子(G-CSF)的使用趋势(生物类似药上市后)

Wang, Ching-Yu; Heldermon, Coy D; Vouri, Scott M; Park, Haesuk; Wheeler, Sarah E; Ramnaraign, Brian Hemendra; Dang, Nam Hoang; Brown, Joshua D